Oxford Biomedica Plc

Oxford Biomedica (OXB)

Buy
Sell
Company name:Oxford Biomedica Plc
EPIC:OXBTrading Currency:GBX
Market Sector:F25TISIN:GB00BDFBVT43
Market Segment:STMMShare Type:DE
WWW Address:http://www.oxfordbiomedica.co.uk/Description:ORD 50P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 1,054.00 images.advfn.com/imagesnew/2/gb/up 12.0 [1.15] 1,054.00 1,056.00 1,042.00 1,060.00 1,020.00 157,724
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 866.63 82.22 -0.01 - - - - 1,082.00 - 620.00

Oxford Biomedica Key Figures

(at previous day's close)
Market Cap.866.63m
Shares In Issue82.22m
Prev. Close1,042.00
PE Ratio- 
Dividend Yield-%
EPS - basic-p
Dividend PS-p
Dividend Cover- 
Cash Flow PS3.79p
Return On Equity (ROE)-5.54%
Operating Margin-7.49%
PEG Factor- 
EPS Growth Rate100.00%
Dividends PS Growth Rate-%
Net Debt24.44m
Gross Gearing38.70%
Quick Assets104.64m
Net Working Capital59.10m
Intangibles / Fixed Assets0.10%
Turnover PS106.69p
Pre-Tax Profit PS-7.99p
Retained Profit PS-7.60p
Cash PS56.85p
Net Cash PS-6.95p
Net Tangible Asset Value PS *137.03p
Net Asset Value PS137.12p
Spread2.00 (0.19%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Oxford Biomedica Balance Sheet

L^OXB:Liabilities+EQL^OXB:Assets

Share Price Performance

Sample Period †HighLow
1 week1,060.00985.00
4 weeks1,060.00935.00
12 weeks1,060.00935.00
1 year1,082.00620.00

Share Price Chart (5 years)

Oxford Biomedica Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1,004.0050.004.98985.000.131,028.67
4 weeks1,020.0034.003.33935.000.16976.42
12 weeks952.00102.0010.71935.000.18997.04
26 weeks799.00255.0031.91775.000.18940.78
1 year714.00340.0047.62620.000.19865.10
3 years583.00471.0080.79366.000.45718.76
5 years265.00789.00297.74150.002.54421.40
† periods calculated are whole weeks rather than calendar months

Oxford Biomedica Key Management Ratios

Oxford Biomedica Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio107.79 
PE Ratio- 
Tobin's Q Ratio 5.65 
Tobin's Q Ratio (excl. intangibles)5.65 
Dividend Yield-%
Market-to-Book Ratio7.69 
Price-to-Pre-Tax Profit PS-131.87 
Price-to-Retained Profit PS-138.77 
Price-to-Cash Flow PS278.12 
Price-to-Sales PS9.88 
Price-to-Net Tangible Asset Value PS7.69 
Price-to-Cash PS18.54 
Net Working Capital PS71.87 
Price Pct to Working Capital PS14.66%
Earnings Yield-%
Average PE61.12 
Years in average1 
PE to PE average-%

Oxford Biomedica Financial Ratios

(Leverage Ratios)
Debt Ratio14.24%
Debt-to-Equity Ratio0.17 
Debt-to-Equity Ratio (excl. Intgbl)0.17 
Debt-to-Equity Market Value0.02 
Net Gearing13.29%
Net Gearing (excl. Intangibles)13.29%
Gross Gearing38.70%
Gross Gearing (excl. Intangibles)38.72%
Gearing Under 1 Year28.52%
Gearing Under 1 Year (excl. Intgbl)28.53%
Assets/Equity1.63 
Cash/Equity41.46 
(Liquidity Ratios)
Net Working Capital to Total Assets32.13%
Current Ratio2.13 
Quick Ratio (Acid Test)1.99 
Liquidity Ratio0.89 
Cash & Equiv/Current Assets41.90%
(Solvency Ratios)
Enterprise Value838.62m
CFO/Sales0.04 
CFO/Attributable Profit- 
CFO/Assets0.02 
CFO/Debt0.04 
Total Debt/Equity Market Value0.08 
Total Debt/Sales0.81 
Total Debt/Pre-Tax Profit-10.83 
Total Debt71.18m
Total Debt/Net Current Assets1.20%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs9 
Beta (60-Mnth)Beta (36-Mnth)
-0.0102-0.0129

Oxford Biomedica Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-5.00%
Return On Assets (ROA)-4.07%
Net Profit Margin-7.12%
Assets Turnover0.57 
Return On Equity (ROE)-5.54%
Return On Investment (ROI)-5.54%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-7.12%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.93 
Fixed Assets Turnover1.31 
Current Assets Turnover1.02 
Net Working Capital Turnover 
Inventory Turnover18.49 
(Other Operating Ratios)
Total Assets-to-Sales1.75 
Debtors-to-Sales55.29%
Debt Collection Period201.82Days

Oxford Biomedica Dividends

Sorry No Data Available

Oxford Biomedica Fundamentals
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
turnover37.59100.00%66.78100.00%64.06100.00%87.73100.00%m
pre tax profit-11.76-31.29%5.017.51%-20.89-32.61%-6.57-7.49%m
attributable profit-9.02-23.99%7.5411.29%-16.07-25.08%-6.25-7.12%m
retained profit-9.02-23.99%7.5411.29%-1.61-2.51%-6.25-7.12%m
eps - basic (p)-0.29 11.57 -22.10 - 
eps - diluted (p)-0.29 10.89 -22.10 - 
dividends per share- - - - 

Oxford Biomedica Balance Sheet

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
L^OXB:Liabilities+EQL^OXB:AssetsL^OXB:Liabilities+EQL^OXB:AssetsL^OXB:Liabilities+EQL^OXB:AssetsL^OXB:Liabilities+EQL^OXB:Assets
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
ASSETS
fixed assets fixed assets25.3738.79%31.7928.28%61.9350.38%72.3039.31%m
intangibles intangibles0.100.15%0.120.10%0.100.08%0.070.04%m
fixed investments fixed investments2.954.52%10.979.76%--%--%m
current assets - other current assets - other--%--%2.722.21%0.240.13%m
stocks stocks3.335.09%4.253.78%2.582.10%6.913.76%m
debtors debtors19.3229.54%33.0329.39%39.3632.02%57.6631.35%m
cash & securities cash & securities14.3321.91%32.2428.69%16.2413.21%46.7425.41%m
TOTAL65.40100%112.40100%122.93100%183.93100%m
LIABILITIES
creditors - short creditors - short21.7633.27%28.5125.36%28.9423.54%52.4628.52%m
creditors - long creditors - long37.4957.33%49.1543.73%18.3614.93%18.7310.18%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL59.2690.60%77.6669.09%47.3038.48%71.1838.70%m
EQUITY
ord cap, reserves ord cap, reserves6.159.40%34.7430.91%75.6361.52%112.7561.30%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL6.159.40%34.7430.91%75.6361.52%112.7561.30%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Oxford Biomedica Cash Flow Statement

31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
Operating CF2.9812.87-3.513.12m
Pre-Financing CF1.052.77-22.91-7.69m
Retained CF-1.0117.92-16.0030.50m

Oxford Biomedica Brokers

NameActivityTypeMnemonicCode
J.P. Morgan Cazenove LimitedMarket Maker(MME)Broker/DealerCAZRCAZEGB2L
Nomura Code Securities LimitedMarket Maker(MME)Broker/DealerCODECODCGB21
Collins Stewart Europe LimitedMarket Maker(MME)Broker/DealerCSCSCSTEGB21
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Panmure Gordon (UK) LimitedMarket Maker(MME)Broker/DealerPMURPMURGB2L
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
OXB
Oxford Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210417 08:38:19